Phase IB study of sorafenib in combination with gemcitabine and cisplatin in patients with refractory solid tumors

被引：0
|
作者：
B. Schultheis
G. Kummer
M. Zeth
E. Brendel
C. Xia
M. Kornacker
D. Strumberg
机构：
[1] University of Bochum (Marienhospital Herne),Department of Haematology and Medical Oncology
[2] Bayer HealthCare Pharmaceuticals,undefined
[3] Bayer HealthCare Pharmaceuticals,undefined
[4] Bayer HealthCare Pharmaceuticals,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2012年 / 69卷
关键词：
Phase I; Sorafenib; Gemcitabine; Cisplatin; Multiple kinase inhibitor; Pharmacokinetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：333 / 339
页数：6
相关论文
共 50 条
  • [31] Phase I trial of everolimus, gemcitabine and cisplatin in patients with solid tumors
    Brian A. Costello
    Mitesh J. Borad
    Yingwei Qi
    George P. Kim
    Donald W. Northfelt
    Charles Erlichman
    Steven R. Alberts
    Investigational New Drugs, 2014, 32 : 710 - 716
  • [32] Pemetrexed/gemcitabine/cisplatin: Phase I trial in patients with solid tumors
    Bolling, C
    Lubbing, C
    Graefe, T
    Mack, S
    Von Scheel, J
    Muller-Hagen, S
    Blatter, J
    Depenbrock, H
    Ohnmacht, U
    Hanauske, AR
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 218S - 218S
  • [33] Phase Ib/II Trial of NC-6004 (Nanoparticle Cisplatin) Plus Gemcitabine in Patients with Advanced Solid Tumors
    Subbiah, Vivek
    Grilley-Olson, Juneko E.
    Combest, Austin J.
    Sharma, Neelesh
    Tran, Richard H.
    Bobe, Lulian
    Osada, Atsushi
    Takahashi, Kazuhiro
    Balkissoon, Jaikrishna
    Camp, Aaron
    Masada, Atsuhiro
    Reitsma, Dirk J.
    Bazhenova, Lyudmila A.
    CLINICAL CANCER RESEARCH, 2018, 24 (01) : 43 - 51
  • [34] Phase I trial of everolimus, gemcitabine and cisplatin in patients with solid tumors
    Costello, Brian A.
    Borad, Mitesh J.
    Qi, Yingwei
    Kim, George P.
    Northfelt, Donald W.
    Erlichman, Charles
    Alberts, Steven R.
    INVESTIGATIONAL NEW DRUGS, 2014, 32 (04) : 710 - 716
  • [35] A PHASE I COMBINATION STUDY OF AZD2281 AND CISPLATIN PLUS GEMCITABINE IN ADULTS WITH SOLID TUMORS
    Rajan, A.
    Gutierrez, M.
    Kummar, S.
    Yancey, M.
    Ji, J.
    Zhang, Y.
    Simmons, D.
    Parchment, R.
    Tomaszewski, J.
    Doroshow, J. H.
    Giaccone, G.
    ANNALS OF ONCOLOGY, 2009, 20 : 42 - 43
  • [36] The combination of sorafenib and everolimus in patients with solid tumors: Results of a phase I study.
    Nogova, L.
    Mattonet, C.
    Scheffler, M.
    Papachristou, I.
    Muthen, N.
    Sos, M.
    Hacker, U. T.
    Elter, T.
    Backes, H.
    Kobe, C.
    Rhiem, K.
    Mallmann, P.
    Fuhr, U.
    Schnell, R.
    Katay, I.
    Toepelt, K.
    Reiser, M.
    Harbeck, N.
    Dietlein, M.
    Wolf, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [37] A phase I study of NC-6004, a micellar formulation of cisplatin, in combination with gemcitabine in Japanese patients with advanced solid tumors
    Hamaguchi, Tetsuya
    Doi, Toshihiko
    Shitara, Kohei
    Iwasa, Satoru
    Shimada, Yasuhiro
    Harda, Mitsunori
    Naito, Kenichiro
    Hayashi, Naoto
    Masada, Atsuhiro
    Ohtsu, Atsushi
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [38] Phase Ib study of axitinib in combination with crizotinib in patients with advanced solid tumors.
    Shepard, Dale Randall
    Bruce, Justine Yang
    Garrido-Laguna, Ignacio
    Rosbrook, Brad
    Martini, Jean-Francols
    Plthavala, Yazdi K.
    Valota, Olga
    Michaelson, M. Dror
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [39] A phase 1b study of crenigacestat (LY3039478) in combination with gemcitabine and cisplatin or gemcitabine and carboplatin in patients with advanced or metastatic solid tumors
    C. Massard
    P. A. Cassier
    A. Azaro
    B. Anderson
    E. Yuen
    D. Yu
    G. Oakley
    K. A. Benhadji
    S. Pant
    Cancer Chemotherapy and Pharmacology, 2022, 90 : 335 - 344
  • [40] A phase 1b study of crenigacestat (LY3039478) in combination with gemcitabine and cisplatin or gemcitabine and carboplatin in patients with advanced or metastatic solid tumors
    Massard, C.
    Cassier, P. A.
    Azaro, A.
    Anderson, B.
    Yuen, E.
    Yu, D.
    Oakley, G., III
    Benhadji, K. A.
    Pant, S.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2022, 90 (04) : 335 - 344
12345